B. Catherwood

发表

Immunoreactive calcitonin in the intermediate lobe of the pituitary gland.

R. Guillemin, R. Moore, L. Deftos, 1978, Life sciences.

Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism.

L. Titus, J. Rubin, G. Hendy, 1991, Endocrinology.

1,25‐Dihydroxyvitamin D reduces parathyroid hormone receptor number in ROS 17/2.8 cells and prevents the glucocorticoid‐induced increase in these receptors: Relationship to adenylate cyclase activation

L. Titus, J. Rubin, M. Nanes, 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Immunohistological studies of artiodactyl and teleost pituitaries with antisera to calcitonin.

W. B. Watkins, L. Deftos, D. Burton, 1980, General and comparative endocrinology.

Determinants of serum 1,25(OH)2D levels in renal disease.

A. Cheung, J. Mitas, R. Blantz, 1983, Kidney international.

General principles, problems and interpretation in the radioimmunoassay of calcitonin.

L. Deftos, B. Catherwood, 1984, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Characterization of a human osteoblastic osteosarcoma cell line (SAOS‐2) with high bone alkaline phosphatase activity

H. Sussman, S. Manolagas, B. Catherwood, 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

1,25(OH)2D3 and cAMP synergistically induce complement 5a receptor messenger RNA.

L. Titus, J. Rubin, M. Nanes, 1996, The American journal of the medical sciences.

Dissociation between ACTH and beta endorphin immunoreactivity in cells of the rat pituitary gland.

L. Deftos, B. Catherwood, 1980, Life sciences.

Tumor necrosis factor α decreases 1,25‐dihydroxyvitamin D3 receptors in osteoblastic ROS 17/2.8 cells

M. Nanes, B. Catherwood, S. Lewis, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Extraction of a substance with calcitonin-like immunoreactivity from pituitary glands of intact and thyroidectomized rats

L. Deftos, H. Bone, B. Catherwood, 1983, Calcified Tissue International.

Measures of bone loss in rheumatoid arthritis.

S. Manolagas, L. Deftos, B. Catherwood, 1986, Archives of internal medicine.

EFFECT OF DAILY ORAL VITAMIN D AND CALCIUM THERAPY, HYPOPHOSPHATEMIA, AND ENDOGENOUS 1–25 DIHYDROXYCHOLECALCIFEROL ON PARATHYROID HORMONE AND PHOSPHATE WASTING IN RENAL TRANSPLANT RECIPIENTS

S. Manolagas, L. Deftos, R. Steiner, 1993, Transplantation.

Expression of C5a anaphylatoxin receptor in monoblastic cells involves facilitation of an adenosine 3',5'-monophosphate-dependent process.

J. Rubin, B. Catherwood, M. Carney, 1988, Endocrinology.

Growth of rat osteoblast‐like cells in a lipid‐enriched culture medium and regulation of function by parathyroid hormone and 1,25‐dihydroxyvitamin D

M. Lorang, B. Catherwood, J. Addison, 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

1,25 Dihydroxyvitamin D causes attenuation of cyclic AMP responses in monocyte-like cells.

J. Rubin, B. Catherwood, 1984, Biochemical and biophysical research communications.

The genetics of multiple endocrine neoplasia syndromes.

M. Nanes, B. Catherwood, 1992, Annual review of medicine.

Premenopausal osteoporosis associated with vitamin D-responsive calcium malabsorption. A case report.

H. Glauber, B. Catherwood, 1987, The American journal of medicine.

Effect of estrogens and phosphorus depletion on plasma calcitonin in the rat

L. Deftos, B. Catherwood, T. Onishi, 1983, Calcified Tissue International.

A Rat Model for Hormone and Mineral Changes in Chronic Renal Failure 1

L. Deftos, H. Bone, B. Catherwood, 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Generation of a carboxyl-terminal fragment of bovine parathyroid hormone by canine renal plasma membranes.

F. Singer, B. Catherwood, 1974, Biochemical and biophysical research communications.

1,25-Dihydroxyvitamin D attenuates cAMP accumulation in cultured human lymphocytes

J. Rubin, B. Catherwood, 1987, Molecular and Cellular Endocrinology.

1,25-Dihydroxyvitamin D3 and adenosine 3',5'-monophosphate synergistically promote differentiation of a monocytic cell line.

J. Rubin, D. Chenoweth, B. Catherwood, 1986, Endocrinology.

Bone turnover in male puberty: A longitudinal study

C. Christiansen, L. Deftos, B. Riis, 1985, Calcified Tissue International.

Glucocorticoids and 1,25-dihydroxyvitamin D3 regulate parathyroid hormone stimulation of adenosine 3',5'-monophosphate-dependent protein kinase in rat osteosarcoma cells.

L. Titus, J. Rubin, M. Lorang, 1988, Endocrinology.

Activation of the 1,25-dihydroxyvitamin D3 receptor in cultured rat osteogenic sarcoma cells.

S. Manolagas, L. Deftos, D. Werntz, 1985, Journal of receptor research.

Serum bone Gla protein and other biochemical estimates of bone turnover in early postmenopausal women during prophylactic treatment for osteoporosis.

C. Christiansen, L. Deftos, J. Pødenphant, 2009, Acta medica Scandinavica.

Rat osteoblasts and ROS 17/2.8 cells contain a similar protein tyrosine phosphatase.

L. Marzilli, L. Titus, J. Rubin, 1993, Bone and mineral.

Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary.

R. Guillemin, R. Moore, L. Deftos, 1978, The Journal of clinical endocrinology and metabolism.

Formation of osteoclast‐like cells is suppressed by low frequency, low intensity electric fields

C. Rubin, L. Titus, J. Rubin, 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Presence by radioimmunoassay of a calcitonin-like substance in porcine pituitary glands.

L. Deftos, B. Catherwood, 1980, Endocrinology.

Distribution of immunoreactive calcitonin in the rat pituitary gland.

R. Moore, L. Deftos, H. Bone, 1980, Endocrinology.

1,25-Dihydroxycholecalciferol and glucocorticosteroid regulation of adenylate cyclase in an osteoblast-like cell line.

B. Catherwood, 1985, The Journal of biological chemistry.

Interferon-gamma inhibits 1,25-dihydroxyvitamin D3-stimulated synthesis of bone GLA protein in rat osteosarcoma cells by a pretranslational mechanism.

L. Titus, J. Rubin, G. Hendy, 1990, Endocrinology.

Increased expression of tissue plasminogen activator messenger ribonucleic acid is an immediate response to parathyroid hormone in neonatal rat osteoblasts.

L. Titus, J. Rubin, S. Boden, 1994, Endocrinology.

Racial differences in pre‐ and postmenopausal bone homeostasis: Association with bone density

D. Meier, S. Wallenstein, R. Lapinski, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Determinants of bone gamma-carboxyglutamic acid-containing protein in plasma of healthy aging subjects.

A. Cheung, R. Marcus, P. Madvig, 1985, Bone.

Calcitonin levels in sera of infants and children: Relations to age and periods of bone growth

L. Deftos, G. Klein, B. Catherwood, 1984, Calcified Tissue International.

Glucocorticoid and 1,25-dihydroxyvitamin D modulate the degree of adenosine 3',5'-monophosphate-dependent protein kinase isoenzyme I and II activation by parathyroid hormone in rat osteosarcoma cells.

L. Titus, J. Rubin, M. Nanes, 1989, Endocrinology.